← Leaderboards
Mercedes R. Rincon
University Of Vermont &St Agric College
$17,614,161
Attributed
$19,123,314
Total exposure
27
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,123,314 · 27
By mechanism
R01$8,610,436 · 4
R21$2,780,301 · 7
R44$2,122,291 · 1
R56$1,520,013 · 4
R25$1,320,189 · 1
P20$1,298,234 · 6
Top collaborators
- Cynthia Arbeeny3 shared
- Julio A Aguirre-Ghiso1 shared
- James V Degregori1 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGenerationsResponseIn VivoPathway InteractionsIn VitroT-LymphocyteAffectCytokineMitochondriaLaboratory MouseImmune ResponseMalignant NeoplasmsLeadMethylationMediatingGenetically Modified AnimalsProteinsMouse ModelPreventRespirationProductionTranscription FactorImmune
Grant awards (66)
Role of respiratory viral infections and inflammation in promoting metastatic outgrowth in the lung$672,011
R01 · FY2025 · CA
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response$377,999
R01 · FY2025 · CA · contact PI
IL-6 and IL-6R genetic polymorphisms in immune-related adverse events caused by cancer immunotherapy$401,115
R21 · FY2024 · CA · contact PI
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response$359,100
R01 · FY2024 · CA · contact PI
A novel approach to treat non-alcoholic steatohepatitis (NASH)$1,008,980
R44 · FY2023 · DK
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response$370,439
R01 · FY2023 · CA · contact PI
GSK3b and dsRNA in CD8 cells$194,375
R21 · FY2023 · AI · contact PI
A novel approach to treat non-alcoholic steatohepatitis (NASH)$860,261
R44 · FY2022 · DK
Enhancing mitochondrial metabolism to improve anti-tumor CD8 immune response$377,999
R01 · FY2022 · CA · contact PI
GSK3b and dsRNA in CD8 cells$233,250
R21 · FY2022 · AI · contact PI
Targeting mitochondrial regulator MCJ to enhance CD8 cell immune response$316,407
R56 · FY2021 · AI · contact PI
A novel approach to treat non-alcoholic steatohepatitis (NASH)$253,050
R44 · FY2021 · DK
Fine-tuning of mitochondrial Complex I activity in CD8 cells$194,510
R21 · FY2021 · AI · contact PI
Fine-tuning of mitochondrial Complex I activity in CD8 cells$247,260
R21 · FY2020 · AI · contact PI
GSK3B in TCR repertoire and immune diseases$401,744
R01 · FY2019 · AI · contact PI
A novel target to overcome chemoresistance in breast cancer$135,072
R21 · FY2019 · CA · contact PI
GSK3B in TCR repertoire and immune diseases$15,628
R01 · FY2019 · AI · contact PI
A novel target to overcome chemoresistance in breast cancer$14,479
R21 · FY2019 · CA · contact PI
Fostering entrepreneurship in biomedical research$440,063
R25 · FY2018 · GM · contact PI
GSK3B in TCR repertoire and immune diseases$388,775
R01 · FY2018 · AI · contact PI
A Novel Treatment for Acetominophen-Induced Liver Injury$264,238
R41 · FY2018 · DK · contact PI
A novel target to overcome chemoresistance in breast cancer$203,580
R21 · FY2018 · CA · contact PI
Fostering entrepreneurship in biomedical research$440,063
R25 · FY2017 · GM · contact PI
GSK3B in TCR repertoire and immune diseases$388,775
R01 · FY2017 · AI · contact PI
A novel approach to treat non-alcoholic steatohepatitis (NASH)$317,953
R41 · FY2017 · DK · contact PI
Fostering entrepreneurship in biomedical research$440,063
R25 · FY2016 · GM · contact PI
GSK3B in TCR repertoire and immune diseases$399,475
R01 · FY2016 · AI · contact PI
IL-6 as a regulator of mitochondria function in T cells$386,041
R56 · FY2016 · AI · contact PI
Regulation of mitochondrial function in T cells$190,625
R21 · FY2015 · AI · contact PI
Regulation of mitochondrial function in T cells$228,750
R21 · FY2014 · AI · contact PI
p38 MAP kinase in early thymocyte development$346,638
R01 · FY2013 · AI · contact PI
IL-6: an innate immune regulator for the plasticity of Tfh cells$441,315
R56 · FY2012 · AI · contact PI
p38 MAP kinase in early thymocyte development$368,763
R01 · FY2012 · AI · contact PI
p38 MAP kinase in early thymocyte development$368,763
R01 · FY2011 · AI · contact PI
p38 MAP kinase in early thymocyte development$372,488
R01 · FY2010 · AI · contact PI
COBRE: UVT: CORE TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC DNA BAC LIBRARY$205,802
P20 · FY2009 · RR · contact PI
p38 MAP kinase in early thymocyte development$188,125
R01 · FY2009 · AI · contact PI
MCJ function in mouse mammary tumor properties$169,313
R21 · FY2009 · CA · contact PI
MCJ function in mouse mammary tumor properties$99,328
R21 · FY2009 · CA · contact PI
p38 MAP kinase in early thymocyte development$376,250
R56 · FY2008 · AI · contact PI
COBRE: UVT: CORE TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC DNA BAC LIBRARY$191,629
P20 · FY2008 · RR · contact PI
MCJ function in mouse mammary tumor properties$169,500
R21 · FY2008 · CA · contact PI
P53 and cell cycle checkpoint by p38 MAP kinase$359,123
R01 · FY2007 · AI · contact PI
COBRE: UVT: CORE TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC DNA BAC LIBRARY$247,316
P20 · FY2007 · RR · contact PI
P53 and cell cycle checkpoint by p38 MAP kinase$369,849
R01 · FY2006 · AI · contact PI
COBRE: UVT: CORE TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC DNA BAC LIBRARY$260,236
P20 · FY2006 · RR · contact PI
P53 and cell cycle checkpoint by p38 MAP kinase$378,750
R01 · FY2005 · AI
COBRE: UVT:CORE TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC$211,245
P20 · FY2005 · RR
Lung epithelium-derived IL-6 in CD4+ T cell immune resp*$378,750
R01 · FY2004 · HL
P53 and cell cycle checkpoint by p38 MAP kinase$375,145
R01 · FY2004 · AI
CORE--TRANSGENIC ANIMAL PROGRAM: MOUSE GENOMIC DNA BAC LIBRARY$182,006
P20 · FY2004 · RR
Lung epithelium-derived IL-6 in CD4+ T cell immune resp*$378,750
R01 · FY2003 · HL
P53 and cell cycle checkpoint by p38 MAP kinase$225,087
R01 · FY2003 · AI
Lung epithelium-derived IL-6 in CD4+ T cell immune resp*$375,660
R01 · FY2002 · HL
p53 and p38 MAP Kinase in thymocyte development$299,144
R21 · FY2002 · AI
NFAT in naive, effector and memory Th1 and Th2 cells$159,181
P01 · FY2002 · AI
Core--Transgenic Animal Program$0
P20 · FY2002 · RR
Core--Transgenic Animal Program$0
P20 · FY2002 · RR
Lung epithelium-derived IL-6 in CD4+ T cell immune resp*$372,600
R01 · FY2001 · HL
NFAT in naive, effector and memory Th1 and Th2 cells$159,181
P01 · FY2001 · AI
NFAT in naive, effector and memory Th1 and Th2 cells$159,181
P01 · FY2001 · AI
SIGNALING PATHWAYS--THYMIC T CELL DEVELOPMENT$106,894
R29 · FY2001 · AI
Core--Transgenic Animal Program$0
P20 · FY2001 · RR
NFAT in naive, effector and memory Th1 and Th2 cells$201,439
P01 · FY2000 · AI
SIGNALING PATHWAYS--THYMIC T CELL DEVELOPMENT$103,783
R29 · FY2000 · AI
Core--Transgenic Animal Program$0
P20 · FY2000 · RR